- Nachrichtendetail
-
18.06.2024 14:05:04 - dpa-AFX: *LIGAND SAYS MERCK RECEIVES FDA APPROVAL FOR PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE FOR ADULTS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Merck & Co | A0YD8Q | NYSE | 115,200 | 02.08.24 03:00:28 | +1,380 | +1,21% | 114,800 | 115,540 | 115,160 | 115,200 |
|
Ligand Pharmaceuticals | A1C9RN | NASDAQ | 100,190 | 02.08.24 23:22:38 | -4,230 | -4,06% | 100,080 | 103,880 | 101,010 | 100,190 |
